← Leaderboards
Jay Nelson
Oregon Health & Science University
$21,289,993
Attributed
$21,289,993
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2014–23$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$21,289,993 · 2
By mechanism
N01$21,289,993 · 2
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Victor Robert Defilippis$6,530,438
- Alec J Hirsch$3,522,343
- Jonah B. Sacha$34,199,132
- Anupriya Agarwal$8,829,719
- Mary Allison Logan$4,475,216
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenLibrariesSmall MoleculeContractorHuman DiseaseAdjuvantSignal PathwayPharmaceutical ChemistryVaccinesCellsAnimal ModelZika VirusLead OptimizationDendritic CellsAntiviral AgentsComputer SimulationChikungunya VirusAntigensImmunologic AdjuvantsFlavivirusB-LymphocytesFda ApprovedHigh Throughput ScreeningEmerging Communicable Diseases
Grant awards (10)
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,104,354
N01 · FY2023 · AI · contact PI
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,267,043
N01 · FY2022 · AI · contact PI
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,090,420
N01 · FY2021 · AI · contact PI
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,202,887
N01 · FY2020 · AI · contact PI
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,061,192
N01 · FY2019 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, Zika and Japanese Encephalitis Virus vaccines$1,668,139
N01 · FY2018 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, Zika and Japanese Encephalitis Virus vaccines$2,513,447
N01 · FY2017 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus vaccines$2,338,653
N01 · FY2016 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus vaccines$2,035,489
N01 · FY2015 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus vaccines$2,008,369
N01 · FY2014 · AI · contact PI